BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ARO-DIMER-PA readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ARO-DIMER-PA\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07223658-1090@assetmemo.bio
DTSTAMP:20261121T005838Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:ARO-DIMER-PA: Phase 1/2 readout est. (NCT07223658)
DESCRIPTION:ARO-DIMER-PA\, phase 1/2\, Mixed Hyperlipidemia.\nStudy: Study 
 of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia\nEstimated 
 primary completion: July 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/aro-dimer-pa#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07223658
URL:https://assetmemo.bio/drug/aro-dimer-pa#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
